Enzene Biosciences Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Holding
- Established
- 2006-08-28
- Employees
- 251
- Market Cap
- -
- Website
- http://www.enzene.com
Clinical Trials
4
Active:2
Completed:0
Trial Phases
3 Phases
Phase 1:1
Phase 3:1
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (50.0%)Phase 1
1 (25.0%)Phase 3
1 (25.0%)A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®
Phase 3
- Conditions
- Postmenopausal Osteoporosis
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Enzene Biosciences Ltd.
- Target Recruit Count
- 504
- Registration Number
- NCT05405725
- Locations
- 🇨🇿
MEDICAL PLUS s.r.o., Uherské Hradiště, Czechia
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Phase 1
Recruiting
- Conditions
- Healthy Male Subjects
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2023-05-30
- Lead Sponsor
- Enzene Biosciences Ltd.
- Target Recruit Count
- 207
- Registration Number
- NCT05245669
- Locations
- 🇧🇬
MC Comac Medical, Sofia, Sofia City Province, Bulgaria
🇵🇱MTZ Clinical Research powered by Pratia, Pratia S.A, Warszawa, Poland
News
No news found